Drug intelligence / Profile preview

芪药消渴胶囊

Development stage: Unknown
Lead developer: Shaanxi Kanghui Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

芪药消渴胶囊 (Qiyao Xiaoke Capsules) is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Shaanxi Kanghui Pharmaceutical for the treatment of diabetes, specifically targeting the traditional Chinese medicine concept of 'xiaoke' (消渴), which is characterized by symptoms such as excessive thirst and urination. As a complex herbal preparation, it is designed to regulate metabolic functions according to TCM principles. The drug is administered orally in capsule form and has been recognized as part of the Shaanxi Province 13115 Major Science and Technology Industrialization Project. It is currently approved and marketed within the Chinese domestic pharmaceutical market as a patent medicine.

Brand names: 芪药消渴胶囊
Other names: Qiyao Xiaoke CapsulesZhiyao Xiaoke Capsules

Beyond the preview

Go deeper on 芪药消渴胶囊.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 芪药消渴胶囊.

Explore the full profile